Federal contract award
75N93019F00131
THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541711 |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | HHSN272201300012I |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $8.8M |
| Current contract value | $8.8M |
| Potential contract value / ceiling | $12.2M |
| Start date | Aug 23, 2019 |
| Current end date | Oct 31, 2026 |
| Potential end date | Oct 31, 2026 |
| Latest award activity | Apr 27, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Apr 27, 2026 | P00009 | $318.0K | THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. |
| May 22, 2025 | P00008 | $1.0M | THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. |
| Jul 31, 2024 | P00007 | $76.7K | THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. |
| Jun 28, 2024 | P00006 | $0 | THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. |
| Nov 17, 2023 | P00005 | $771.8K | THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. |
| Sep 11, 2023 | P00004 | $0 | THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. |
| Aug 9, 2023 | P00003 | $0 | THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. |
| Aug 24, 2022 | P00002 | $3.1M | THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. |
| Aug 29, 2021 | P00001 | $0 | THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. |
| Aug 23, 2019 | 0 | $3.5M | THIS TASK ORDER IS FOR THE DEVELOPMENT OF A PROTOCOL, CLINICAL TRIAL IMPLEMENTATION, CLOSEOUT AND ANALYSIS OF A PHASE 2 CLINICAL TRIAL TO EVALUATE THE EFFICACY OF RMENB+OMV NZ (BEXSERO, GSK) IN PREVENTING N. GONORRHOEAE INFECTION. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.